Polymersomes as a potential platform for cancer immunotherapy

With the focus in field of cancer nanomedicine shifting from direct tumor targeting to modulation immune system, new opportunities arise for employment nanocarrier systems. Polymeric nanovesicles, or polymersomes, have been under investigation as a potential platform past decades. These investigations enhanced our fundamental knowledge on how tailor physicochemical properties, such size and shape, surface chemistry functionalization, membrane characteristics. The versatile nature high structural stability polymersomes makes them suitable treatment that goes beyond drug delivery. Rational design allows spatiotemporal control over function specific cell targets enhance immunotherapy. This review provides perspective view multifunctional vivo We discuss implement field, elaborate their considerations immunotherapeutic applications compare with lipid nanoparticles other relevant Current challenges future perspectives are addressed underline what is needed employ